| Hang Seng Index | 24.200 HKD | +0.200 | +0.833% | 617.02M | 14.82B | 24.002 (+0.827%) HKD as at 2025/03/21 | | |
| Hang Seng China Enterprises | 90.360 HKD | +0.900 | +1.006% | 144.52M | 12.94B | 89.426 (+1.044%) HKD as at 2025/03/21 | | |
| Hang Seng TECH Index | 5.605 HKD | +0.095 | +1.724% | 1.33B | 7.35B | 5.521 (+1.520%) HKD as at 2025/03/21 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 6.500 HKD | +0.245 | +3.917% | 262.03M | 1.66B | 6.297 (+3.219%) HKD as at 2025/03/21 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.720 HKD | -0.070 | -3.911% | 804.37M | 1.42B | 1.785 (-3.620%) HKD as at 2025/03/21 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 2.462 HKD | -0.054 | -2.146% | 152.21M | 381.48M | 2.533 (-2.803%) HKD as at 2025/03/21 | | |
| Hang Seng TECH Index | 12.000 HKD | +0.170 | +1.437% | 29.27M | 347.23M | 12.235 (-1.917%) HKD as at 2025/03/20 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.370 HKD | +0.100 | +1.898% | 53.65M | 283.49M | 5.224 (+2.803%) HKD as at 2025/03/21 | | |
| Hang Seng TECH Index | 7.255 HKD | +0.130 | +1.825% | 23.60M | 168.54M | 7.146 (+1.528%) HKD as at 2025/03/21 | | |
| Hang Seng TECH Index | 5.690 HKD | +0.100 | +1.789% | 28.32M | 159.06M | 5.599 (+1.620%) HKD as at 2025/03/21 | | |
| FTSE China A50 | 13.830 HKD | +0.130 | +0.949% | 11.49M | 158.59M | 13.991 (-1.150%) HKD as at 2025/03/20 | | |
| CSI 300 | 43.620 HKD | +0.300 | +0.693% | 2.15M | 93.23M | 44.106 (-1.101%) HKD as at 2025/03/20 | | |
| CSI 300 | 28.120 HKD | +0.240 | +0.861% | 1.59M | 44.74M | 28.379 (-0.913%) HKD as at 2025/03/20 | | |
| London Gold Fixing Price | 2,167.000 HKD | -7.000 | -0.322% | 17.05K | 36.92M | N/A | | |
| FTSE China A50 | 12.960 HKD | +0.150 | +1.171% | 2.36M | 30.51M | 12.845 (+0.892%) HKD as at 2025/03/21 | | |
| Hang Seng China Enterprises | 10.990 HKD | +0.100 | +0.918% | 2.67M | 29.15M | 10.964 (+0.237%) HKD as at 2025/03/20 | | |
| MSCI Asia APEX 50 | 57.400 HKD | +0.420 | +0.737% | 453.08K | 25.82M | 57.537 (-0.238%) HKD as at 2025/03/20 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 5.585 HKD | -0.175 | -3.038% | 4.02M | 22.52M | 5.741 (-2.714%) HKD as at 2025/03/20 | | |
| Hang Seng High Dividend Yield | 25.460 HKD | -0.020 | -0.078% | 887.60K | 22.51M | 25.804 (-1.334%) HKD as at 2025/03/20 | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 10.700 HKD | +0.390 | +3.783% | 1.98M | 21.07M | 10.335 (+3.528%) HKD as at 2025/03/21 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises | 3.510 HKD | +0.084 | +2.452% | 5.51M | 18.91M | 3.398 (+3.284%) HKD as at 2025/03/21 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 10.590 HKD | -0.090 | -0.843% | 1.21M | 12.84M | 10.752 (-1.508%) HKD as at 2025/03/21 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | CSI 300 | 3.742 HKD | +0.058 | +1.574% | 2.94M | 10.91M | 3.706 (+0.961%) HKD as at 2025/03/21 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 14.550 HKD | -0.110 | -0.750% | 699.60K | 10.17M | 14.712 (-1.104%) HKD as at 2025/03/20 | | |
| CSI Hong Kong Dividend | 33.900 HKD | 0.000 | 0.000% | 274.40K | 9.22M | 33.607 (+0.872%) HKD as at 2025/03/21 | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 6.705 HKD | +0.250 | +3.873% | 1.29M | 8.57M | 6.482 (+3.434%) HKD as at 2025/03/21 | | |
| CME Bitcoin Futures | 30.280 HKD | +1.080 | +3.699% | 273.21K | 8.25M | 29.269 (+3.454%) HKD as at 2025/03/20 | | |
| CSI 300 | 40.720 CNY | +0.380 | +0.942% | 186.80K | 7.57M | 41.077 (-0.870%) CNY as at 2025/03/20 | | |
| MSCI India Net Total Return (USD) Index | 6.650 HKD | +0.090 | +1.372% | 1.08M | 7.17M | 6.482 (+2.597%) HKD as at 2025/03/20 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | NASDAQ-100 Index | 22.160 HKD | +0.700 | +3.262% | 256.10K | 5.65M | 21.528 (+2.937%) HKD as at 2025/03/20 | | |